NIPRO

Investor Relations

IR News

November 21, 2025
Toward NIPRO's Sustainable Growth
November 10, 2025
Consolidated Financial Results for the Six Months Ended September 30, 2025 [Japanese GAAP] / Notice Regarding Difference between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 2025 / IR Materials
September 30, 2025
Annual Report

Index

News Release

November 20, 2025
Announcement of Spryte Medical, a US Affiliate of NIPRO, Receives FDA IDE Approval to Initiate "INSYTE" US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment (135KB)
November 4, 2025
Notice of Personnel Changes (165KB)
October 28, 2025
Notice Concerning Acquisition of Shares of G2/Spryte Holdco, LLC (to Make It a Subsidiary) (130KB)

Index